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Available online 8 May 2007Newer MRI methods can detect cerebral abnormalities not identified
on routine imaging in patients with focal epilepsy. Correlation of MRI
with histopathology is necessary to understand the basis of MRI
abnormalities and subsequently predict histopathology from in vivo
MRI. The aim of this study was to determine if particular quantitative
MR parameters were associated with particular histological features.
Nine patients with temporal lobe epilepsy were imaged at 1.5 T
using standard presurgical volumetric and quantifiable sequences:
magnetization transfer and FFT2. The resected temporal lobe was
registered with the volumetric MRI data according to our previously
described method to permit correlation of the modalities. Stereo-
logically measured neuronal densities and field fraction of GFAP,
MAP2, synaptophysin and NeuN immunohistochemistry were ob-
tained. Analyses were performed in the middle temporal gyrus and
compared with quantitative MRI data from the equivalent regions.
There was a significant Spearman Rho negative correlation
between NeuN field fraction and the T2 value in gray matter
(correlation coefficient −0.72, p=0.028). There were no significant
correlations between any neuropathological and MR measures in white
matter.
These preliminary findings suggest that T2 in gray matter is
sensitive to the proportion of neuronal tissue. Novel quantitative MRI
measures acquired with higher field strength magnets, and so with
superior signal to noise ratios, may generate data that correlate with
histopathological measures. This will enable better identification and
delineation of the structural causes of refractory focal epilepsy, and will
be of particular benefit in patients in whom current optimal MRI does
not identify a relevant abnormality.
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The structural basis of focal epilepsy has a major effect on the
natural history of the condition in an individual patient (Semah et
al., 1998). In 30% of patients, epilepsy is refractory to current drug
treatments. In patients with drug-resistant focal epilepsy, surgical
resection may be curative, and the nature of the underlying lesion
influences post-operative outcome (McIntosh et al., 2001; Luders
and Schuele, 2006).
MRI has greatly facilitated assessment for epilepsy surgery by
revealing underlying structural cerebral abnormalities. When
optimal MRI and post-operative neuropathological examination
of the resection specimen do not identify an underlying structural
abnormality, seizure outcome from surgery is less likely to be good
(Blume et al., 2004; Jeha et al., 2006), reflecting the absence of a
discrete, removed abnormality or one that is currently undetectable
by imaging or pathology. This is to some extent a self-fulfilling
strategy, such that patients in whom no structural abnormality is
identified may not be considered for surgery (Spencer et al., 2005).
Even optimal MRI, however, may not reveal known underlying
pathological substrates such as focal cortical dysplasia and mild
malformations of cortical development (Palmini et al., 2004),
which are evident on histopathological examination of the resected
tissue (Lee et al., 2005; Widdess-Walsh et al., 2006).
Thus, there is a pressing need for further developments in MRI,
such as higher field strengths to improve signal-to-noise ratio, and
newer sequences that may better pick out culpable neuropatholo-
gical lesions in the neocortex.
The correlations between hippocampal volumes and T2
measures with glial and neuronal densities were established more
than a decade ago (Cascino et al., 1991; Van Paesschen et al., 1995).
For the more recently developed MR contrasts, the correlation
between MR parameters and the underlying neocortical structure is
not well understood and it is important for this to be clarified if these
contrasts are to contribute to presurgical evaluation.
Quantitative histopathology has developed in parallel with MRI
and led to more accurate and sophisticated interpretation of
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previously shown that temporal lobe resection specimens and
their resultant histological slides can be aligned with pre-operative
volumetric MRI data, allowing comparison of advanced MRI data
sets in regions of interest to the equivalent areas on histopatho-
logical slides (Eriksson et al., 2005). Thus, quantitative MRI data
and quantitative histopathological data can be directly compared.
In this study we compared the data obtained using two quantitative
MRI contrasts, T2 relaxation time maps (T2); and magnetization
transfer ratio (MTR), with quantitative neuropathological data from
the resected material. The aim was to explore the clinical utility of
T2 and MTR and determine if particular quantitative MR
parameters were associated with particular histological features.
Methods
Subjects
We studied nine consecutive patients for temporal lobe epilepsy
surgery at the National Hospital for Neurology and Neurosurgery
who had had pre-operative advanced MRI and in whom resection
specimens were processed according to our protocol (Eriksson
et al., 2005). The study was approved by the Joint Research Ethics
Committee of the National Hospital for Neurology and Neurosur-
gery and Institute of Neurology, UCL. All patient and control
subjects gave written informed consent to participate in the study.
The age range of subjects was 31–46 years (median 36 years)
and 4 were male. Seven had a right anterior temporal lobe
resection, and two had surgery on the left. The surgical procedure
was selected after our standard presurgical work-up, including
EEG-video telemetry, conventional MRI (T1- and T2-weighted,
proton density and FLAIR), psychological and psychiatric
assessments and multi-disciplinary case conference.
Control groups for the advanced MRI consisted of healthy
volunteers with no history of neurological disease and normal
conventional MRI and were the same subjects as reported
previously (Salmenpera et al., 2007). Twenty-nine volunteers
served as a control population for the analysis of T2 maps and 26
volunteers for MTR.
MR acquisition
All scans were acquired on the same 1.5 T GE Signa MR
scanner (GE Medical Systems, Milwaukee, WI). The T1-weighted
volume sequence from the conventional scan protocol for all
subjects was required for the MR:pathology correlation. The
sequence parameters were: TE/TR/TI/NEX, 4.2/15/450/1; flip
angle 20°; acquisition matrix 256×192; field of view 24×18 cm;
3/4 phase FOV, 124 contiguous 1.5 mm slices, giving a voxel size
of 0.94×1.25×1.5 mm.
Subjects had two additional scans to generate quantitative MR
data:
T2 mapping
Dual-echo CSF suppressed, FFT2 (fast FLAIR T2) data sets
were acquired using TR/TI/TE1,2=5000/1638/15,120 ms. Twenty-
eight contiguous axial slices were obtained with an acquisition
matrix of 256×256 and a 24 cm in-plane field of view, giving a
voxel size of 0.94×0.94×5 mm. T2 signal intensity was calculated
pixel-by-pixel using the dual-echo data sets, one set from the early
echo (TE1) and one from the late echo (TE2), according to theequation: T2 signal= (TE2−TE1) / ln (S1/S2) where S1 and S2
represent the signal intensities for the early and late echoes
respectively (Rugg-Gunn et al., 2005). Total acquisition time was
13 min and 50 s.
Magnetization transfer imaging
Magnetization transfer (MT)-weighted and non-MT-weighted
three-dimensional data sets were acquired using TR/TE=22.6/
5.4 ms. Volume matrix was 256×256 (in-plane)×124 over a
240×240×180 mm field of view, giving a voxel size of
0.94×0.94×1.5 mm. MT-weighted images were collected after
the application of a pre-pulse to saturate the broad resonance of
immobile macromolecule protons. The MT radiofrequency pulse
used was a three-lobe Hamming apodized sinc pulse with a duration
of 6.4 ms and of 5.1 μT, applied 2 kHz off-resonance (Rugg-
Gunn et al., 2003). Total acquisition time was 13 min and 54 s.
MRI quantitation
Voxel-by-voxel statistical comparisons were performed on each
of the two image contrasts. This process used SPM99 (Wellcome
Dept. of Imaging Neuroscience, Institute of Neurology, London,
UK) to produce intensity probability maps that were normalized to
a standard space defined by a template of all the controls
(Salmenpera et al., 2007). The normalized T2 maps were smoothed
with a 4 mm and MTR maps an 8 mm isotropic Gaussian kernel to
improve signal to noise ratio, to allow the images to conform more
closely to a Gaussian field model and to increase the validity of
statistical inference. A standard univariate t-test was applied using
SPM99 to every voxel in the image in order to create a map from
which statistical inference was drawn. Significant increases or
decreases in MR contrast signal intensity were detected at an
individual voxel threshold of pb0.001. The theory of Gaussian
fields was used to calculate a corrected multiple comparison p
value of 0.05. We tested for regional differences in intensity
between each patient and the control group. Further details of the
image processing are given in a previous paper (Salmenpera et al.,
2007).
Quantitative MR values were obtained by overlaying a region
of interest on the quantitative MR data. The mean intensity value
of all voxels within the region of interest was calculated.
MR:pathology visual correlation
All subjects had a standard anterior temporal lobe resection
performed by the same surgeon. During and after resection,
specimens were processed according to standard histopathological
and co-registration protocols and digital images of the tissue blocks
were correlated with the pre-operative volumetric MRI data
(Eriksson et al., 2005). Briefly, after fixation the resected temporal
lobe was sliced in 5 mm blocks perpendicular to the maximum
linear extent of the superior temporal sulcus. The MR volume data
were rotated and reformatted into an oblique coronal plane that
matched the orientation of these blocks. These oblique coronal
images were visually inspected in comparison to the pathological
blocks. Using standardized criteria, the best fit MRI slice for any
one pathological block was identified and matches for adjacent
blocks of tissue ensued. Two raters (SF and SE) performed this task
separately and reached a consensus in any case with discrepancy.
All subjects had post-operative MRI scans to indicate the extent
of the resection.
Fig. 1. Example of images used for field fraction of NeuN immunohistochemistry. (a) Gyral crown of middle temporal gyrus at ×1.6 magnification (NeuN
immunohistochemistry counterstained with H&E, 20 μm slice thickness). All cortical layers were included in the analysis. (b) Higher magnification (×40) from
the same specimen, used for field fraction analyses. Note that neuronal cell bodies, not only nuclei, are immunopositive, but there is only limited involvement of
axons and dendrites. (c) Same field as in b with pixels immunopositive for NeuN highlighted in green. The RGB parameters representing immunopositive pixels
(brown) are set in the first field analyzed.
Table 1
Surgical and quantitative MRI data (within the resected tissue)
Subject Gender Age TLx MTR T2 Outcome
1 M 36 R Dec Inc 1
2 M 35 R 2
3 F 44 R 1
4 M 28 R 3
5 F 46 R 3 Inc 1
6 F 31 R 4
7 F 40 R Inc 1
8 F 37 L 2 Inc 3
9 M 33 L 1
TLx: side of temporal lobe surgery; R: right; L: left; Inc: increased signal
compared to controls identified using SPM; MTR: magnetization transfer
ratio; Dec: decreased signal compared to controls; 2 Inc: 2 regions of
increased signal etc. Outcome according to ILAE criteria (Wieser et al.,
2001) after a minimum of 1 year: 1 no seizures; 2 auras only; 3 seizures on
less than 4 days a year; 4 seizures reduced by more than 50%.
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Standard laboratory protocols were used to prepare resected
tissue in sections stained for Nissl (cresyl violet/LFB), glial
fibrillary acidic protein (GFAP; Dako, Cambridge, UK; poly-
clonal 1:1500) and neuronal nuclear antigen (NeuN; Chemicon,
Temecula, CA, USA, monoclonal 1:2000). An experienced
epilepsy neuropathologist (MT) made a qualitative tissue
assessment for clinical purposes. For quantitative histopathology
the following sections were used: the standard 7 μm GFAP
sections; additional 20 μm sections stained with NeuN; 20 μm
sections stained for microtubule associated protein (MAP2;
SIGMA, Saint Louis, MO, USA; 1:2000); 7 μm sections stained
with anti-synaptophysin antibody (Dako, Cambridge, UK; 1:100).
All sections were processed in the same batch to ensure uniform
immunostaining, which is important when assessing the field
fraction, which relies on the intensity of staining. A commercial
image analysis system (Histometrix, Kinetic Imaging, Liverpool,
UK), attached to a Zeiss Axioskop microscope, was used to
generate quantitative histopathology measures. Two regions of
tissue were assessed in each subject: ROI1 in the deep white
matter of the middle temporal gyrus (a region identified from
MRI-directed correlation, see below); and ROI2, in the cortex in
the gyral crown of the middle temporal gyrus. Quantitative
measures in ROI1 were: stereological counts of neurons; field
fraction estimates of immunostaining for GFAP, MAP2 and
synaptophysin. Quantitative measures in ROI2 were stereological
counts of neurons and field fraction estimates of staining for
NeuN and GFAP. The stereological neuronal counts were
performed as previously described (Eriksson et al., 2006). For
field fraction estimates the ROI was outlined on the computer
screen of the image analysis system at ×2.5 magnification. The
number of fields within the ROI to be analyzed was chosen (70–
90 in our study) and the computer software randomly chose a
starting point and then a field spacing to cover the whole ROI at
the relevant sampling rate. All cortical layers were included in the
analysis. Magnification was then increased to ×40 and each field
displayed on the computer screen. In the first field for analysis,
light intensity parameters were optimized to visualize the
immunopositive pixels and the RGB (red-green-blue) parameters
representing immunopositive pixels were set. Light intensity and
RGB parameters were kept constant for all subsequent fields. The
software program then automatically estimated the number ofimmunopositive pixels as a proportion of the entire field. An
average of field fraction for all fields was calculated, thus
reporting a single field fraction value for each ROI in a given
patient. RGB parameters were defined uniquely for each case
before analyses as signal intensity can vary slightly between
cases. An example of images used for field fraction analyses in
one patient is shown in Fig. 1. Measures in ROI1 were made by
an experienced epilepsy neuropathologist (MT) and measures in
ROI2 by a neurologist (SE) with extensive experience of quan-
titative neuropathology.
Histopathology and MRI correlation
MRI-directed
Abnormal regions in the SPM results for the MRI data were
observed for several subjects (Table 1). To correlate MRI data
with histopathological analyses in the same area in all cases,
region of interest analyses were performed. A region that had
abnormal T2 signal on voxel based analysis in one subject that
was within the deep white matter of the middle temporal gyrus
was selected and designated ROI1. This region was of sufficient
size to provide robust histopathological data (Eriksson et al.,
2006) and was present in tissue which had been resected in all 9
Fig. 2. Normalization protocol. (a) Each subject's T1-weighted volume MRI scan was normalized to the T1 image template in SPM99, using the default
normalization protocol. (b) The normalized T1-weighted image was hence in the same space as ROI1 and both could be reverse normalized to subject space using
the parameters derived from the original normalization (a). (c) ROI1 could then be transferred to the equivalent histopathological section using the previously
determined MRI:pathology correlation.
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SPM analyses were normalized to SPM space, quantitative MTR
and T2 data could be achieved by superimposing ROI1 on each
case's normalized MTR and T2 data.
To achieve quantitative histopathological data, the ROI was
aligned with the volume MRI of each patient by a sequence of two
normalizations as follows (Fig. 2).
Each subject's volume MRI (cropped and tilted as used for the
initial MR:pathology correlation) was normalized to the T1 image
template in SPM99 using the default normalization protocol in
SPM99 (Fig. 2). The T1 image template was in the same image
space as ROI1, thus ROI1 could be associated with each subject's
normalized MRI. The normalized volume was then back normal-
ized to the volume MRI in each subject's native image space. The
parameters used for the back-normalization were also used to
transform ROI1 from T1 space back to the native space (Fig. 2).
This ROI could then be transferred to the equivalent pathological
space by visual inspection of the previously determined MRI:
pathology correlation (Fig. 2). Thus ROI1 was located on the
pathology slices of each subject. This region, directly drawn onto
the pathology slides of interest, was used for subsequent quan-
titative histopathology. An example of the images of ROI1 for one
subject is shown in Fig. 3.
We also defined a region in the pathological data and
determined its MR characteristics. To achieve this, the MRI vol-
ume data were segmented in subject space using intensity
thresholding and manual drawing in Analyze AVW 5.0 (BIR,
Mayo Clinic, Minnesota). The entire resection volume and theFig. 3. Example of placement of ROI1. (a) The original T1-weighted volume MRI
right temporal lobe on T1-weighted volume MRI seen in a. (c) Zoomed T1-weigh
ROI1 shown overlaid in white onto the T1-weighted image. (d) Zoomed image of th
space. The same normalization parameters were used for both the T1-weighted imag
the MRI slice (GFAP, 7 μm slice-thickness), showing ROI1, outlined with red mamiddle temporal gyrus within the resection volume were extracted
by manual drawing guided by visual inspection of the previously
determined MR:pathology correlation. Intensity thresholding and
visual inspection were used to separate gray and white matter. A
final manual segmentation step was used to separate the gray
matter of the gyral crown (ROI2), from the gray matter in the rest
of the middle temporal gyrus. This step used similar criteria to
characterize the limits of the gyral crown as were used by the
neuropathologist in the quantitative neuropathology. The data from
the initial MR:pathology correlation were used to determine which
MR slices within the middle temporal gyrus in each subject
corresponded to ROI2. Each subject's MR volume data were
registered to the advanced MR image data in the native subject
space using SPM99 and the default registration option. Because of
the different qualities of the T2 maps and MTR image data,
different registration was performed and different templates used
that more closely resembled the two data sets.
For the MTR images, the segmented gray and white matter
(summed) were used, while the MR volume data were registered
to the proton density image which was acquired simultaneously
with the T2 data, thus effectively registering the MR volume to
the T2 data. Once optimal registration parameters were identified,
these were used to register ROI2 in the MR volume data to the
T2 maps and MTR data sets (Fig. 4). Thus, for example, gray
matter in the middle temporal gyrus could be identified on the T2
image and T2 values determined for the gray matter in that
region. An example of the images of ROI2 for one subject is
shown in Fig. 5.in subject space with a line demarcating the resection. (b) Zoomed image of
ted volume MRI after normalization into SPM space, with region of interest
e T1-weighted volumeMRI and ROI1 after the back normalization to subject
e and ROI1. (e) The equivalent histopathological slice which correlates with
rker.
Fig. 4. Registration protocol for ROI2. (a) The gyral crown of the middle temporal gyrus was identified on each patient's histopathological specimen (ROI2). (b)
ROI2 was then determined on the corresponding T1-weighted volume scan using Analyze AVW 5.0. (c) The T1 volume scan was then registered to the PD
images (and hence also the T2 images that were acquired simultaneously) using the SPM99 default registration options (registration 1). (d) The summed
segmented T1 volume MRI (used to achieve image quality similar to MTR images) was registered to the MTR images using default options in SPM99
(registration 2). (e and f) The parameters from the two registrations were used to register ROI2 from T1 volume space to each patient's individual T2 and MTR
space.
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using SPSS (version 11.0.0).
Results
Careful correlation of abnormal regions in the SPM data and the
resected tissue indicated that regions that were abnormal on SPM
analysis were physically present in the resected tissue in four
patients (Table 1). In one patient (patient 3) qualitative neuro-
pathology identified a hamartia (a subtle malformation of cortical
development) in the white matter approximately 3 mm in diameter
(Table 2). This was not detected using the SPM analysis and was
not a part of ROI1 or ROI2. The abnormal region in one patient
(T2 region in patient 5) was in the white matter of the middle
temporal gyrus and was labeled as the region of interest, ROI1. The
quantitative histopathology and quantitative MR data for this
region for the nine patients are given in Table 3. Spearman Rho
correlation did not reveal any significant correlations between any
of these pathological and MR measures. This region had an
abnormal average T2 value in one other patient (patient 1) but MT
values were within the normal range for all subjects. ClusteringFig. 5. Example of placement of ROI2. (a) A histopathological slice used to estimate
indicated in red (NeuN, 20 μm slice thickness). (b) The corresponding volume MR
temporal lobe on T1-weighted volume MRI seen in b. (d) The same image as in c w
gyrus defined after segmentation of the MRI volume data set) overlaid. (e) Zoome
appropriate registration.analysis of the histopathological data could not separate the two
patients with abnormal T2 values from those subjects with normal
T2 values in ROI1.
Quantitative histopathology was determined for the gray matter
in the gyral crown of the middle temporal gyrus. The registration
process enabled us to determine quantitative MR data for the same
region (ROI2) (Table 4). There was a significant Spearman Rho
negative correlation between the field fraction measure of NeuN
and the T2 value in ROI2 (correlation coefficient −0.72,
p=0.028).
Discussion
We have previously shown that in vivo MRI and pathological
blocks may be aligned using visual inspection and a standardized
protocol (Eriksson et al., 2005). We have now shown that, with
additional registration protocols, quantitative parameters from MRI
and histopathology can be directly compared. There was a negative
correlation between the histopathological field fraction measure of
NeuN immunopositivity and the MR measure of T2 relaxation time
in the gray matter of the middle temporal gyrus. This is the firstquantitative histopathology in the gyral crown of the middle temporal gyrus,
I slice with a line demarcating the resection. (c) Zoomed image of the right
ith the region of interest ROI2 (i.e. the cortical crown of the middle temporal
d image of the right temporal lobe on MTR images overlaid by ROI2 after
Table 2
Qualitative histopathological data in the complete resection specimen
(whole temporal lobe and hippocampal specimens)
Subject Diagnosis
1 DNT
2 Hamartia in white matter, approximately 2 mm diameter,
insufficient hippocampal material to allow confirmation of
classic HS, but no evidence of neuronal loss or gliosis in CA1
3 Hippocampal gliosis—no classical HS, marked cortical
gliosis and moderate white matter atrophy
4 HS
Possible neuronal loss from outer cortical layers with abnormal
neuronal orientation, moderate superficial cortical gliosis and
white matter atrophy
5 HS
Prominent superficial cortical and white matter gliosis
6 Hippocampal gliosis, insufficient hippocampal material to
allow confirmation of classic HS, gliosis of entorhinal cortex
and neocortex
7 HS, moderate superficial cortical and white matter gliosis
8 Ganglioglioma, patchy moderately severe gliosis in deeper
cortical layers
9 HS, neuronal loss and excessive gliosis in superficial cortical
laminae in anterior temporal lobe
DNT: dsyembryoplastic neuroepithelial tumor; HS: hippocampal sclerosis.
Table 4
Quantitative histopathology and quantitative MR for gray matter (ROI2), in
all subjects
Subject GFAP GMNeu NeuN T2 MTR
1 0.09 4.31 0.08 117 40
2 0.04 4.20 0.12 111 44
3 0.11 6.16 0.13 102 46
4 0.17 2.89 0.11 92 47
5 0.15 3.89 0.08 118 46
6 0.05 3.86 0.11 110 47
7 0.12 4.04 0.10 105 46
8 0.09 4.05 0.10 118 40
9 0.10 3.17 0.10 112 45
Values of GFAP and NeuN are all field fraction proportions as in Table 3.
GMNeu: gray matter neuronal density, neurons ×10−5/μm3.
T2 relaxation time (ms).
MTR p.u. (percentage units).
GFAP: glial fibrillary acidic protein; NeuN: neuronal nuclear antigen; MTR:
magnetization transfer ratio.
Mean of difference for repeat measures of field fraction for GFAP, 0.06 (SD
0.06); NeuN, 0.012 (SD 0.007).
Mean T2 value in this ROI for control subjects was 101 (SD 3.5, coefficient
of variation 3.5%) and mean MTR for control subjects was 46 (SD 1.8,
coefficient of variation 3.9%).
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logical data from neocortex in patients with epilepsy.
We wished to compare the same area in all patients because it is
not known how much histopathological measures and MR
parameters differ as a function of location within cerebral tissue.
Although some of the histopathological features of interest were
readily quantified with a semi-automated protocol, stereological
measures require significant expert time input. In consequence, we
restricted this study to two regions of interest. The first region
investigated corresponded to a region of abnormal T2 signal onTable 3
Quantitative histopathology and quantitative MR for white matter (ROI1), in
all subjects
Subject MAP2 Synaptophysin GFAP WMNeu T2 MTR
1 0.17 0.09 0.53 4.17 111 39
2 0.14 0.14 0.22 4.06 104 43
3 0.26 0.09 0.30 2.40 99 43
4 0.19 0.06 0.35 2.18 99 43
5 0.21 0.12 0.23 2.76 119 49
6 0.15 0.06 0.32 0.98 102 43
7 0.18 0.06 0.45 2.28 102 45
8 0.17 0.12 0.39 2.53 107 44
9 0.20 0.03 0.69 1.37 109 46
Values of MAP2, Synaptophysin and GFAP are all field fraction proportions
for MAP2, synaptophysin and GFAP respectively.
WMNeu: white matter neuronal density, neurons ×10−6/μm3.
T2 relaxation time (ms).
MTR p.u. (percentage units).
MAP2: microtubule associated protein 2; GFAP; glial fibrillary acidic
protein; MTR: magnetization transfer ratio; SD: standard deviation.
Mean difference between repeat measurements for field fraction for MAP2,
0.037 (SD=0.042); synaptophysin, 0.011 (SD 0.2); GFAP, 0.1 (SD=0.13).
Mean T2 value in this ROI for control subjects was 99 (SD 3.1, coefficient of
variation 3.1%) and mean MTR for control subjects was 49 (SD 2.2,
coefficient of variation 4.5%).SPM analysis in one patient and was chosen since it was of
sufficient size to provide robust histopathological data and was
available in all resections. Our second region was identified in each
subject's histopathological sections, the gray matter of the crown
of the middle temporal gyrus overlying ROI1, giving us data in
adjacent gray matter.
The limitation of the initial MR and pathology matching is that
the matching was visual and was guided by anatomy and was to
some extent subjective. Our previous study, however, showed that
the protocol gave consistent, reliable and accurate registrations
within the structural limitations of the histopathological data
(Eriksson et al., 2005). The subsequent matching of specific MR or
pathology regions with their respective pathology or MR regions
was carried out using computational normalization and registration,
both of which were entirely repeatable. This may seem a complex
procedure when, for example, the middle temporal gyrus is
generally readily identified on anatomical MRI. However, the
advanced quantitative MR sequences are optimized for the
appropriate MR parameter and not for visualization of anatomy
and it can therefore be difficult to confidently identify anatomical
features using these contrasts. Identifying the structure of interest
in a high quality anatomical scan and then using registration and/or
normalization protocols reduced the number of subjective steps
(only one definition of the tissue structure was required rather than
one in each MR scan) and therefore reduced computation time and
increased repeatability.
The T2 signal in MRI is dependent upon the relationship
between bound and free water in a tissue, which is itself dependent
upon the macromolecular environment. Disruption of tissue
integrity can result in an increase in the free water in tissue and
an increase in T2 relaxation time. Changes in T2 in the cerebrum
have been related to, among other processes, gliosis, demyelina-
tion, edema, neuronal loss and infarction. In an earlier study from
our group, significant increases in T2 signal were observed in 51%
of patients with cryptogenic focal epilepsy (Rugg-Gunn et al.,
2005). The MTR signal is dependent upon the exchange of
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depends upon the integrity of the macromolecular environment.
Changes in MTR have been related to histopathologic changes of
axonal loss, gliosis, demyelination and edema (Lexa et al., 1994;
Brochet and Dousset, 1999). Our earlier study found reductions of
MTR in acquired lesions, malformations of cortical development
and in regions that were normal on conventional MRI (Rugg-Gunn
et al., 2003). In the present study ROI1 was defined by an
abnormal T2 value in one subject. Additional analysis revealed that
this region also had an abnormal T2 signal in one other subject.
MTR values were normal in this region in all subjects. There were
no significant linear correlations between the MR values and the
histopathological values in ROI1 in our group. The two subjects
with abnormal T2 values did not differ from the other seven
subjects in relation to their standard or quantitative histopatholo-
gical data. The T2 and MTR values were all normal in ROI2.
There was a significant negative correlation between the T2
relaxation time and the field fraction estimate of NeuN staining in
the cortex of the middle temporal gyrus. A decrease in NeuN
staining could suggest a reduction in the number of mature neurons
in the tissue, altered packing density or alterations in cell size or
NeuN immunoreactivity. An increase in T2 signal has been
correlated with neuronal loss and increased gliosis (Van Paesschen
et al., 1997; Rugg-Gunn et al., 2005). Increased gliosis may further
reduce the relative concentration of neurons in a region, although
sometimes, tissue sclerosis or gliosis causes reduction in tissue
volume which could paradoxically increase packing density. We
did not observe any relationship between T2 value and GFAP field
fraction. Thus, the correlation detected may reflect a consistent
biological relationship focused on neuronal loss. However, one
subject had neocortical neuronal loss observed during routine
qualitative neuropathology (Case 4). This subject had the lowest
value of neuronal count in the gray matter of ROI2 (the crown of
the middle temporal gyrus) but also the lowest value of T2 in ROI2
which appears contrary to the correlation observed in the whole
group. The reason for this is not clear. The cortical NeuN field
fraction in this case was 0.11 (range 0.08–0.13).
Gray matter neuronal counts did not correlate with the field
fraction estimate of NeuN. The gray matter neuronal counts are a
count for each neuron observed in the region of interest expressed
as a proportion of the total area assessed. The field fraction
estimate of NeuN is an estimate of the area occupied by tissue
immunopositive for NeuN as a proportion of the total area
assessed. This tissue is predominantly neuronal cell bodies with
some axons and dendrites. Thus 5 large neurons will occupy a
greater area of immunopositivity than 5 small neurons. The
neuronal count would be the same in each case but the field
fraction would be different. This may explain the lack of
correlation between the field fraction and the neuronal count.
The relation of these two measures with the T2 relaxation value
suggests that the T2 relaxation is dependent on more than just the
number of neurons, also on their size or complexity, which may
reflect their function. Further staining protocols and analyses of
neuronal size are necessary to elucidate further this difference.
The lack of any other correlations between the MR and the
histopathology measures could be due to a number of factors. A
real correlation may exist and not have been detected, possibly
because of the limited number of subjects in the study. A change of
MR scanner curtailed data collection for this series and we are now
recruiting more subjects imaged using a new 3 T scanner. We could
also have missed a true correlation because the registrationbetween the MR region and the pathological region was inadequate
as discussed previously.
Alternatively, there may not be any other true correlations
between the MRI sequences and pathological measures studied. The
pathological measures characterize real physical features — for
example, the actual number of neurons and the proportion of tissue
affected by gliosis. However, the underlying physical significance of
the MR data is not yet well characterized. We may have chosen
pathological measures which do not relate to the features
characterized by the MR signals. Myelin content, for example,
might influence both T2 and MTR. We did not think it likely that
myelin studies would be of relevance in epilepsy in the context of
this paper, but additional histopathological analyses, such as LFB for
myelin or myelin basic protein, may lead to further useful data in
future studies.
Therewas also limited tissue specificity for absolute T2 andMTR
values betweenwhite and graymatter (see Tables 3 and 4 for details).
Thus the MR measures and the histopathology measures may be
measuring different features of the tissue and would not be expected
to correlate. A hamartia, seen as a cluster of neurons in the white
matter microscopically, was not detected as an abnormal MR region
with either MTR or T2 using SPM. There are new histopathological
techniques in development and some of these may prove a better
match to the MR signal changes. MR acquisition on a 3 T scanner
will produce data with better signal-to-noise qualities and improved
spatial resolution and may increase the sensitivity of quantitative
MR measures. Further correlations of quantitative histopathology
and quantitative MRI measures may lead to derivation of MRI
measures that are most sensitive to pathological changes.
Our protocol for matching MR and pathology has demonstrated
how we can investigate both the histopathology directed by an MR
finding and the MR data directed by a histopathological finding.
We identified a biologically plausible correlation between an
increased T2 relaxation time and a reduction in neuronal labeling
in the cortex of the middle temporal gyrus. If newer, quantitative
MRI sequences are to be adopted more widely in routine clinical
practice, further research exploring their underlying biological and
pathological substrates will be necessary and may ultimately lead
to a reduction in the proportion of patients with drug-resistant focal
epilepsy whose optimal MRI is said to be “normal”.
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